GZGang Zhu

Gang Zhu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Gang Zhu has a total of 30 co-authors. Here are the top co-authors by number of shared publications:

  • Kai Zhang

    Department of Urology Beijing United Family Hospital and Clinics Beijing China

    4 shared publications
  • Hongbo Li

    Department of Urology, Beijing United Family Hospital and Clinics, Beijing, China

    3 shared publications
  • Lei Wang

    Department of Urology, Peking University Shougang Hospital, Peking University Wu Jieping Urology Center, Beijing, China

    2 shared publications
  • Yanqun Na

    Department of Urology, Peking University Shougang Hospital, Peking University Wu Jieping Urology Center, Beijing, China

    2 shared publications
  • Cheng Pang

    Graduate School of Peking Union Medical College, Beijing Department of Urology, Beijing Hospital of the Ministry of Health, Beijing

    1 shared publication
  • Chi-Fai Ng

    The Chinese University of Hong Kong

    1 shared publication

Latest Publications

  • Open Access

    Irreversible Electroporation for the Focal Treatment of Prostate Cancer: A Systematic Review

    by Kai Zhang, Jeremy Teoh, Gang Zhu, Chi-Fai Ng, Michel Suberville, Pilar Laguna, Jean de la Rosette

    Zhang K, et al. World J Mens Health. 2024 Jul;42:e65. https://doi.org/10.5534/wjmh.240012


  • Open Access

    Application of holographic imaging in partial nephrectomy: a literature review

    by Lei Wang, Yanqun Na, Gang Zhu

    Objectives: The aim of the present review was to evaluate the role of holographic imaging and its visualization techniques in providing more detailed and intuitive anatomy of the surgical area and assist in the precise implementation of surgery. Materials and methods: Medline, Embase, and Cochrane Central databases were searched for literature on the application of holographic imaging in partial nephrectomy (PN), and the history, development, application in PN as well as the future direction were reviewed. Results: A total of 304 papers that met the search requirements were included and summarized. Over the past decade, holographic imaging has been increasingly used for preoperative planning and intraoperative navigation in PN. At present, the intraoperative guidance method of overlapping and tracking virtual three dimensional images on endoscopic view in an augmented reality environment is generally recognized. This method is helpful for selective clamping, the localization of endophytic tumors, and the fine resection of complex renal hilar tumors. Preoperative planning and intraoperative navigation with holographic imaging are helpful in reducing warm ischemia time, preserving more normal parenchyma, and reducing serious complications. Conclusions: Holographic image-guided surgery is a promising technology, and future directions include artificial intelligence modeling, automatic registration, and tracking.


  • Comparison of Mirabegron plus Tamsulosin and Tamsulosin Monotherapy for the Treatment of Ureteral Stent-Related Symptoms: A Prospective Randomized Study

    by Kai Zhang, Wei Yan, Hongbo Li, Jie Chen, Qian Wang, Yali Chai, Lihua Yuan, Gang Zhu

    Introduction: The aim of this study was to compare the efficacy of mirabegron plus tamsulosin to tamsulosin monotherapy in terms of ureteral stent-related discomfort after ureteroscopic lithotripsy. Methods: A total of 102 patients undergoing ureteroscopic lithotripsy and silicone ureteral stent placement were enrolled in this study. Patients were randomized 1:1 to receive either tamsulosin 0.4 mg once daily or mirabegron 50 mg + tamsulosin 0.4 mg once daily during the stenting period. Before the operation, the IPSS, QOL, and pain score were collected. On the day of ureteral stent removal, the USSQ, analgesic usage amount was collected and recorded. Results: The median USSQ-body pain score in the tamsulosin group and tamsulosin + mirabegron group was 15 and 16, respectively (p = 0.530). The median analgesic usage in the two groups was 3 and 2, respectively (p = 0.170). The median USSQ-urinary symptoms, USSQ-general health, USSQ-work performance, USSQ-sexual matters, and USSQ-additional problems in the two groups were 26 and 26 (p = 0.194), 11 and 12 (p = 0.068), 12 and 13 (p = 0.105), 2 and 2 (p = 0.437), 9 and 9 (p = 0.533), respectively. The international patients used more analgesics than Chinese patients (6 vs. 1, p = 0.015). Conclusion: Compared to tamsulosin alone, tamsulosin + mirabegron showed no additional benefit on the ureteral stent-related pain control after ureteroscopic lithotripsy and silicone stent placement. There was no significant difference on the analgesic usage and USSQ scores between the two groups. Chinese patients request fewer analgesics than international patients.


  • Combination of holographic imaging with robotic partial nephrectomy for renal hilar tumor treatment

    by Kai Zhang, Lei Wang, Ying Sun, Wei Wang, Shuaiying Hao, Hongbo Li, Jingjing Lu, Derek A. O’rEilly, Yanqun Na, Gang Zhu

    Objectives To evaluate the clinical value of the holographic imaging technology in combination with robotic-assisted partial nephrectomy (RAPN) for renal hilar tumor treatment. Patients and methods From Dec. 2018 to Dec. 2021, patients diagnosed with renal hilar tumor were included in this retrospective study. Before the surgery, the engineers established the holographic image models based on the enhanced CT data. The models were used in patient consultation, pre-surgery planning and surgery simulation. During the RAPN, the navigation was achieved by real-time overlapping of the holographic images on the robotic surgery endoscopic views. The navigation technique helped the surgeon to identify the important anatomic structures such as tumor, renal vein, renal artery, and pelvis. Results There were total of eight patients with renal hilar tumor who underwent RAPN combined with holographic imaging technique. The mean age was 57.3 years, the median ASA score was 2. The mean tumor size was 42.4 mm and the median RENAL Nephrometry score was 9.5. The clinical stages were cT1a (37.5%) and cT1b (62.5%). All the procedures were performed uneventfully by one surgeon. The mean operative time was 144.3 min, and the mean warm ischemia time was 27.9 min. The mean estimated blood loss was 86.3 ml. There was no conversion to open surgery or radical nephrectomy. There were no Clavien–Dindo ≥ 3 perioperative complications. Conclusions Using the holographic imaging technique, the pre-surgery planning, simulation of renal arterial clamp and excision of the tumor, and intraoperative navigation were feasible and helpful in facilitating RAPN.


  • Open Access

    Robot-assisted laparoscopic retroperitoneal lymph node dissection with concomitant inferior vena cava thrombectomy for metastatic mixed testicular germ cell cancer: a case report

    by Kai Zhang, Gang Zhu, Xingshuai Liu, Jiangke Tian, Yanfei Gu, Mengyao Zhai, Lu Yang, Wei Liu, Hongbo Li, Francisco J. Martinez Portillo

    The robot-assisted laparoscopic management of post-chemotherapy retroperitoneal metastasis and inferior vena cava tumor thrombus secondary to testicular cancer is a challenging task for urologists. A pathological examination of a 36-year-old Caucasian man who had undergone a right radical orchiectomy showed mixed testicular germ cell cancer (70% embryonal cancer and 30% seminoma); he had undergone four prior courses of cisplatin, etoposide, and bleomycin chemotherapy and was found to have residual retroperitoneal enlarged lymph nodes close to the right renal hilum and a 9.8 cm inferior vena cava tumor thrombus (pT1, N2, M1, S2). Pre-surgical three-dimensional image reconstruction was performed based on contrast computed tomography data. The inferior vena cava tumor thrombus was found in the vena cava at the level of the celiac trunk and the inferior mesenteric artery. Our patient accepted treatment with robot-assisted laparoscopic retroperitoneal lymph node dissection with concomitant inferior vena cava thrombectomy and cava reconstruction on September 12, 2018. During the procedure, a drop-in robotic ultrasound probe was used to define the thrombus. Vena cavoscopy using a flexible ureteroscope found that the tumor thrombus adhered to the cava wall in all directions. The tumor thrombus was dissected free from the inferior vena cava lumen, and vena cava reconstruction was achieved using the da Vinci™ Si HD surgical system. The operative time was 550 minutes. The intraoperative estimated blood loss was 2300 ml. Intraoperative blood transfusions consisted of 10 units of red blood cells (Clavien-Dindo grade II). No Clavien-Dindo grade III or above perioperative complications occurred. The length of hospital stay was 7 days. Pathology revealed no viable cancer cells in any of the residual lymph node tissues or in the vena cava tumor thrombus. This is the first case of robot-assisted laparoscopic retroperitoneal lymph node dissection with concomitant inferior vena cava thrombectomy and reconstruction for metastatic mixed testicular germ cell cancer published to date. This complicated surgical procedure was facilitated by the innovative usage of three-dimensional image reconstruction for defining the vena cava tumor thrombus, a robotic ultrasound probe for intraoperatively defining the vena cava tumor thrombus, and vena cavoscopy using a flexible ureteroscope.


  • Urologic cancer in China

    by Cheng Pang, Youyan Guan, Hongbo Li, Wanqing Chen, Gang Zhu

    Cancer remains to be the second most common cause of death, and its incidence and mortality rates are increasing in China. According to the 2015 National Central Cancer Registry (NCCR) of China, the incidence of bladder cancer and prostate cancer ranked sixth and seventh, respectively, in male cancers. The majority of prostate cancer patients were diagnosed at an advanced stage. Early diagnosis of prostate cancer is the key to improve prostate cancer survival in China. Radical prostatectomy or radical radiotherapy is the main treatment for localized prostate cancer, and a comprehensive therapy based on androgen deprivation therapy is the treatment for advanced disease. The most common histologic types of bladder cancer in China were urothelial carcinoma, followed by adenocarcinoma and squamous carcinoma. The majority of patients were diagnosed using white-light cystoscopy with biopsy. Fluorescence and narrow-band imaging cystoscopy had additional detection rates and are becoming more popular. Following Chinese guidelines, most non-muscle invasive bladder cancer patients were treated with diagnostic transurethral resection and more than half of the muscle invasive bladder cancer patients were treated with radical cystectomy. Due to the increased detection rate of kidney tumors by ultrasound in physical examination, the number of incidentally diagnosed renal cell carcinoma has increased. Localized kidney cancers are more and more often treated by nephron-sparing surgery. Radical nephrectomy is still the main treatment option for patients with locally advanced renal cell carcinoma. Both laparoscopic and robotic-assisted laparoscopic surgeries have been used in big medical centers. Both testicular cancer and penile cancer have lower incidence levels than that in Europe. As we have an enormous population base, the absolute patient number is big. The diagnosis and treatment follows the Chinese guidelines. In China, both medical professionals and public should concern more on the early diagnosis, as there is not enough cancer prevention information available. Urologists should also take a more active role in educating the population.